B1 Vertaisarvioitu muu artikkeli (esim. pääkirjoitus, letter, comment) tieteellisessä lehdessä

Time, the final frontier




TekijätFollain, Gautier; Dibus, Michal; Joshi, Omkar; Jacquemet, Guillaume

KustantajaWILEY

KustannuspaikkaHOBOKEN

Julkaisuvuosi2025

JournalMolecular Oncology

Tietokannassa oleva lehden nimiMOLECULAR ONCOLOGY

Lehden akronyymiMOL ONCOL

Sivujen määrä6

ISSN1574-7891

eISSN1878-0261

DOIhttps://doi.org/10.1002/1878-0261.70025

Verkko-osoitehttps://doi.org/10.1002/1878-0261.70025

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/491440443


Tiivistelmä

Cancer's notorious heterogeneity poses significant challenges, as each tumor comprises a unique ecosystem. While single-cell and spatial transcriptomics advancements have transformed our understanding of spatial diversity within tumors, the temporal dimension remains underexplored. Tumors are dynamic entities that continuously evolve and adapt, and relying solely on static snapshots obscures the intricate interplay between cancer cells and their microenvironment. Here, we advocate for integrating temporal dynamics into cancer research, emphasizing a fundamental shift from traditional endpoint experiments to data-driven, continuous approaches. This integration involves, for instance, the development of advanced live imaging techniques, innovative temporal omics methodologies, and novel computational tools.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
This article was supported by the Research Council of Finland (338537 to GJ), the Sigrid Juselius Foundation (to GJ), the Cancer Society of Finland (Syöpäjärjestöt; to GJ), and the Solutions for Health strategic funding to Åbo Akademi University (to GJ).This research was also supported by the InFLAMES Flagship Programme of the Academy of Finland (decision numbers: 337530, 337531, 357910, 35791). GF was supported by the Turku Collegium for Science, Medicine, and Technologies. MD was supported by the European Union’s Horizon Europe research and innovation program under the Marie Sklodowska-Curie grant agreement no.: 101108089. OJ was supported by the University of Turku Graduate School Doctoral Programme in Technology (DPT) (#2300668) and the Finland Fellowship 2023.


Last updated on 2025-23-06 at 13:47